AVP BioPharma Consult ApS: Financial statements 2020
CVR: 37770426
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,106,641 and a net result of DKK 189,764 compared with DKK 319,722 the year before. That is a decrease of 24.4% compared with the year before. Equity in the 2020 report amounted to DKK 294,975. The solvency ratio was 61.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,106,641
- Profit/Loss
- DKK 189,764
- Equity
- DKK 294,975
- Total Assets
- DKK 478,524
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.1M | 190K | 295K | 1 |
| 2019 | - | 1.5M | 320K | 375K | 1 |
| 2018 | - | 1M | 71K | 126K | 1 |
| 2017 | - | 1.1M | 58K | 142K | 1 |
Official annual report
How creditworthy is AVP BioPharma Consult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AVP BioPharma Consult ApS has published its annual report for 2019. Gross profit came to DKK 1,462,906, and the net result was DKK 319,722.
About AVP BioPharma Consult ApS
AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.
